InnoVen raises $200m from Temasek, UOB
InnoVen Capital, a venture debt firm active in India, China, and Southeast Asia, has raised $200 million from its primary shareholders Temasek Holdings and United Overseas Bank (UOB).
The new commitment was split evenly between Temasek and UOB, each of which has owned a 50% stake in the firm since 2015. InnoVen will use the capital to expand its lending portfolio across Asia. The firm...
More on Southeast Asia
Latest News
Chinese O2O language training provider files for US IPO
Meten International Education Group, a Chinese online-to-offline (O2O) English language training provider that mainly caters to adult students, has filed for a US IPO. DG Capital is the primary PE investor in the company.
Singapore's VisVires launches $150m food tech fund
VisVires New Protein, a Singapore-based VC firm specializing in food technology, has launched its second fund with a target of $150 million. Fund I closed at $40 million in 2016.
China’s Allist Pharmaceuticals raises $171m Series A
Shanghai-based drug developer Allist Pharmaceuticals has raised RMB1.2 billion ($171 million) in a Series A round of funding led by Shiyu Capital. Other participants include Loyal Valley Capital and Suzhou Industrial Park Bioventure Investment.
SBI joins $35m Series B for Japan's Pixie Dust
SBI Investment, the VC arm of Japan’s SBI Holdings, has joined a JPY3.8 billion $35 million Series B round for Pixie Dust Technologies, a local company developing novel uses for ultrasonic waves.